Viewpoints in clinical proteomics: When will proteomics deliver clinically useful information?
Article first published online: 28 AUG 2012
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
PROTEOMICS - Clinical Applications
Volume 6, Issue 7-8, pages 343–345, August 2012
How to Cite
Borrebaeck, C. A. K. (2012), Viewpoints in clinical proteomics: When will proteomics deliver clinically useful information?. Prot. Clin. Appl., 6: 343–345. doi: 10.1002/prca.201200020
- Issue published online: 28 AUG 2012
- Article first published online: 28 AUG 2012
- Accepted manuscript online: 14 JUN 2012 03:22AM EST
- Manuscript Accepted: 16 MAY 2012
- Manuscript Received: 27 MAR 2012
Despite massive efforts, proteomics has not delivered biomarkers of clinical value. However, the technologies that are emerging today have the power to reach deep into proteomes and identify the patterns associated with different diseases. Study design is then crucial and sample quality, bioinformatics approaches, prevalidation, using independent patient cohort need to attract increased attention before proteomics will contribute to the needs of personalized medicine.